Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471128 | SCV000561679 | likely benign | Epilepsy, progressive myoclonic, 1B | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000828448 | SCV000970137 | likely benign | not provided | 2018-05-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000828448 | SCV001475417 | likely benign | not provided | 2019-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023027 | SCV002737235 | likely benign | not specified | 2018-12-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |